641 results match your criteria: "Ion Chiricuță Oncology Institute[Affiliation]"

Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) is a rare and aggressive molecular subtype of hepatocellular carcinoma (HCC) associated with a poor prognosis. Unlike typical HCC, which commonly arises in the context of cirrhosis, MTM-HCC can develop in non-cirrhotic livers, presenting unique diagnostic and therapeutic challenges. This case report describes a 35-year-old male who presented with persistent epigastric pain, fatigue, and loss of appetite.

View Article and Find Full Text PDF

Wnt Signaling Pathway in Tumor Biology.

Genes (Basel)

December 2024

Department of Hematology, Ion Chiricuta Oncology Institute, 400015 Cluj Napoca, Romania.

Relapse and metastasis are the major challenges that stand in the way of cancer healing and survival, mainly attributed to cancer stem cells (CSCs). Their capabilities of self-renewal and tumorigenic potential leads to treatment resistance development. CSCs function through signaling pathways such as the Wnt/β-catenin cascade.

View Article and Find Full Text PDF

The Antioxidant, Antimicrobial, and Antitumor Proprieties of Flavonol-Rich Extracts from (Wild Garlic) Leaves: A Comparison of Conventional Maceration and Ultrasound-Assisted Extraction Techniques.

Int J Mol Sci

November 2024

Centre for Systems Biology, Biodiversity and Bioresources, Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babes-Bolyai University, 5-7 Clinicilor Street, 400006 Cluj-Napoca, Romania.

Despite the growing interest in using natural compounds for disease prevention and treatment, (wild garlic), known for its therapeutic properties, has not been extensively studied for its chemical composition and biological activities. Therefore, this study aims to explore the in vitro antioxidant, antibacterial, and antitumor activities of extracts according to their functional phytochemical profile, while assessing whether ultrasound-assisted extraction (UAE) enhances bioactive properties in comparison to conventional maceration (CM). Both extracts were characterized by spectrophotometric methods and LC-ESI+-MS.

View Article and Find Full Text PDF

Diagnostic Value of Nuclear Hybrid Imaging in Malignant Struma Ovarii: A Systematic Review of Case Reports.

Diagnostics (Basel)

November 2024

Faculty of Medicine, Department of Medical Imaging and Nuclear Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 8 V. Babeș St., 400006 Cluj-Napoca, Romania.

Background: Struma ovarii is a rare tumor, a type of ovarian mature teratoma consisting over 50% of its mass in thyroid ectopic tissue; 5% to 10% of cases, as described in the literature, are malignant and well known as malignant struma ovarii or thyroid cancer from struma ovarii. Due to the limited number of malignant struma ovarii cases, the diagnostic and therapeutic approach of malignant struma ovarii lacks in standardization.

Methods: We performed a comprehensive search on the English language PubMed and Google Scholar.

View Article and Find Full Text PDF

Background: Brain metastases (BM) from gastric cancer (GC) are rare but associated with poor prognosis, significantly impacting patient survival and quality of life. The objective of this systematic review and meta-analysis is to consolidate existing research on BM from GC, evaluate the incidence and clinical outcomes, and explore the effectiveness of treatment options.

Methods: A systematic search was conducted across the Medline, Web of Science, and Scopus databases, following PRISMA guidelines.

View Article and Find Full Text PDF

Lynch syndrome (LS) is one of the most common hereditary cancer syndrome in human populations, associated with germline variants in MLH1, MSH2/EPCAM, MSH6 and PMS2 genes. The advent of next generation sequencing has proven a significant impact in germline variant detection in the causative genes; however, a large proportion of patients with clinical criteria still receive uncertain or negative results. PMS2 is the least frequent reported gene, associated with up to 15% of LS cases with late-onset disease and low penetrance phenotype; however, the proportion of PMS2-LS cases is considered to be highly underestimated.

View Article and Find Full Text PDF
Article Synopsis
  • - Vasculitis is a rare condition that causes inflammation of blood vessels and can affect various body systems, making diagnosis and treatment challenging due to its diverse symptoms.
  • - Large vessel vasculitis (LVV), specifically giant cell arteritis (GCA) and Takayasu arteritis (TAK), can lead to severe health issues, and early detection is vital to prevent potential organ damage.
  • - Imaging techniques like CT angiography, ultrasound, MRI, and PET-CT play a crucial role in diagnosing LVV by showing signs of vessel wall changes, and a collaborative approach among healthcare professionals is essential for better patient care.
View Article and Find Full Text PDF

Lung Cancer in Romania.

J Thorac Oncol

November 2024

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Department of Pathology, BC Cancer Agency, Vancouver, Canada.

View Article and Find Full Text PDF

Background And Aims: Non-small cell lung cancer (NSCLC) treatment is challenged by late detection and limited therapeutic options. Aberrant DNA methylation, a common epigenetic alteration in NSCLC, offers new therapeutic avenues. This study aims to evaluate the combined effects of 5-Azacytidine (5-Aza), an epigenetic modifier, and ionizing radiation (IR) on NSCLC, exploring the underlying molecular mechanisms and therapeutic potential.

View Article and Find Full Text PDF

Objectives: Interval debulking surgery has similar outcomes and less morbidity compared with primary debulking in advanced ovarian cancer. However, there is controversy regarding the selection of chemotherapy-resistant clones. Complete resection is an essential prerequisite, and near-infrared surgery combined with various techniques for highlighting malignant foci strives to achieve actual complete resection.

View Article and Find Full Text PDF

Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.

J Hematol

October 2024

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.

Article Synopsis
  • Castleman disease (CD) is a rare non-cancerous condition that can be unicentric or multicentric (MCD), with MCD leading to serious symptoms due to cytokine issues, particularly involving interleukin-6 (IL-6).
  • This study examined the real-world effectiveness of siltuximab, an anti-IL-6 therapy recommended for idiopathic MCD, in treating patients in Greece and Romania from 2017 to 2022.
  • Out of 48 patients treated, 71.1% had a response to the treatment, with a 3-year survival rate of 74%, but some patients experienced adverse effects like elevated liver enzymes and anxiety.
View Article and Find Full Text PDF

Background: Acute lymphoblastic leukemia (ALL) is the most prevalent cancer in children, with continuously improving survival rates. As few studies in Romania have analyzed ALL patients and disease characteristics or survival, we conducted a retrospective study on 158 patients diagnosed with ALL admitted to the Department of Pediatric Oncology and Hematology at the Emergency Hospital for Children, Cluj-Napoca, Romania, from January 2011 until April 2021. The most important objectives of the study are to establish full profiles of the patients and ALL, remission rates, relapses, and deaths, an epidemiology analysis to determine the incidence of ALL for comparison with the standard European population, and also to assess survival by the most important parameters, including minimal residual disease (MRD).

View Article and Find Full Text PDF

Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer.

Medicina (Kaunas)

October 2024

Department of Oncological Surgery and Gynecological Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.

Article Synopsis
  • Sarcopenia, characterized by muscle mass loss, is found in up to 68% of rectal cancer patients and negatively affects survival and tumor response, although research on its impact in locally advanced rectal cancer (LARC) is limited.
  • A study at the Prof. Dr. Ion Chiricuta Institute of Oncology examined 50 LARC patients who underwent total neoadjuvant treatment (TNT), assessing muscle mass via MRI before and after therapy.
  • The findings showed that a lower overall complete response rate (oCR) of 18% was significantly tied to post-treatment sarcopenia, and patients who experienced muscle loss during therapy had worse clinical outcomes and higher instances of cystitis and thrombocytopenia.
View Article and Find Full Text PDF

Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia.

Biomedicines

October 2024

Regina Maria" Regional Laboratory in Cluj-Napoca, 34-36 Republicii Str., 400015 Cluj-Napoca, Romania.

Acute myeloid leukemia (AML) is a heterogenous malignant hemopathy, and although new drugs have emerged recently, current treatment options still show limited efficacy. Therapy resistance remains a major concern due to its contribution to treatment failure, disease relapse, and increased mortality among patients. The underlying mechanisms of resistance to therapy are not fully understood, and it is crucial to address this challenge to improve therapy.

View Article and Find Full Text PDF

: In recent years, cardiac dysfunction in childhood cancer survivors has become an important issue. Studies are focusing on identifying means for the early identification of patients at risk. Considering this, our study aims to investigate 24-hour Holter electrocardiogram (ECG) repolarization changes throughout doxorubicin (DOX) and cyclophosphamide (CPM) administration in pediatric patients treated for acute lymphoblastic leukemia (ALL).

View Article and Find Full Text PDF
Article Synopsis
  • * Analyzing a cohort of 51 patients, the median disease-free survival (DFS) was 46 months, with significant correlations found between DFS and factors like IMDC score, neutrophil to lymphocyte ratio, tumor size, and Fuhrman nuclear grade.
  • * Notably, 51% of patients experienced disease relapse, with 42% of these relapses occurring after 60 months post-surgery, indicating the importance of long-term monitoring for nmRCC patients.
View Article and Find Full Text PDF

Background: Dysregulated pathways in cancer may be hub addicted. Identifying these dysregulated networks for targeting might lead to novel therapeutic options.

Objective: Considering the hypothesis that central hubs are associated with increased lethality, identifying key hub targets within central networks could lead to the development of novel drugs with improved efficacy in advanced metastatic solid tumors.

View Article and Find Full Text PDF

The road to overcome pancreatic cancer: Where are we?

Heliyon

October 2024

Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 400337, Cluj-Napoca, Romania.

Pancreatic cancer (PC) is an intricate malignancy with poor prognosis. In the present state of the art review paper and clinical trial trend analysis, we explore the current clinically employed state of pancreatic cancer body of knowledge and future research directions. When considering PDACs' molecular biology, we underline the role of PanIN in carcinogenesis and mutational gain, as well as the distinctive tumor microenvironment with the characteristic dense fibrotic stroma.

View Article and Find Full Text PDF
Article Synopsis
  • Alström disease is a rare genetic disorder linked to mutations in the ALMS1 gene, causing diverse issues across multiple organ systems, including heart and sensory problems, but with significant variability between patients.
  • The case study focuses on a 4-month-old girl who showed symptoms like dilated cardiomyopathy and neurosensory deficits, prompting genetic testing that confirmed Alström syndrome.
  • The findings highlight the challenges in linking specific genetic mutations to clinical symptoms, underscoring the need for more research on phenotype-genotype relationships in Alström disease.
View Article and Find Full Text PDF

MiRNAs are a class of non-coding RNAs acting as gene expression regulators by modulating the lifespan of messenger RNA. Commonly referred to as the most frequent leukemia in the Western world, chronic lymphocytic leukemia (CLL) is a lymphoproliferative malignancy characterized by clonal expansion of CD19, CD23, and CD5-positive mature B-cells. While this pathology is regarded as less aggressive and has a variety of treatment options, the cause of its clinical heterogeneity is not yet understood.

View Article and Find Full Text PDF

Background And Objectives: Rectal cancer accounts for approximately one-third of colorectal cancers, with over 340,000 deaths globally in 2022. Despite advancements in treatment, the five-year overall survival for locally advanced rectal cancer (LARC) remains at 74%, with significant morbidity. B7H3 (CD276), an immune checkpoint protein, plays a role in tumor progression and resistance to therapy, and correlates with poor prognosis in various cancers, including colorectal cancer.

View Article and Find Full Text PDF

Prostate cancer (PC) represents the second most common diagnosed cancer in men. The burden of diagnosis and long-term treatment may frequently cause psychiatric disorders in patients, particularly depression. The most common PC treatment option is androgen deprivation therapy (ADT), which may be associated with taxane chemotherapy.

View Article and Find Full Text PDF

The role of magnetic resonance imaging (MRI) in rectal cancer management has significantly increased over the last decade, in line with more personalized treatment approaches. Total neoadjuvant treatment (TNT) plays a pivotal role in the shift from traditional surgical approach to non-surgical approaches such as 'watch-and-wait'. MRI plays a central role in this evolving landscape, providing essential morphological and functional data that support clinical decision-making.

View Article and Find Full Text PDF

Dual-Modal Near-Infrared Organic Nanoparticles: Integrating Mild Hyperthermia Phototherapy with Fluorescence Imaging.

Int J Nanomedicine

September 2024

Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania.

Article Synopsis
  • The study aims to create dual-modal organic-nanoagents for treating early-stage cutaneous melanoma, focusing on improving cancer therapy and real-time imaging techniques using nanotechnology and NIR molecular imaging.
  • PLGA nanoparticles were developed to encapsulate a specific near-infrared dye, tested for their effectiveness, stability, and biocompatibility both in vitro and in vivo, showing promising results in enhancing photothermal therapy for melanoma treatment.
  • Findings indicated that the nanoparticles could efficiently induce localized hyperthermia in tumor regions, promoting cellular death and immune response while minimizing damage to surrounding healthy tissue, suggesting a potential for more effective and safer melanoma therapies.
View Article and Find Full Text PDF